24 HR Glipizide 10 MG Extended Release Oral Tablet
1 INDICATIONS AND USAGE Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablet is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Rising Pharmaceuticals, Inc.
ROUND WHITE P 10
Related Pills
glipizide 2.5 mg
rising pharmaceuticals, inc.
glipizide 5 mg
rising pharmaceuticals, inc.
Glipizide 10 mg
rising pharmaceuticals, inc.
loratadine 10 mg
spirit pharmaceuticals llc
propranolol 10 mg
dispensing solutions, inc.
loratadine 10 mg
spirit pharmaceuticals llc
acetazolamide 500 MG 12 HR Extended Release Capsule
Zydus Pharmaceuticals (USA) Inc.
gabapentin 100 MG Oral Capsule
AvKARE, Inc.
gabapentin 300 MG Oral Capsule
AvKARE, Inc.
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
Rebel Distributors Corp
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
American Health Packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
GLIPIZIDE extended-release tablets are supplied to provide 2.5 mg, 5 mg, and 10 mg round, biconvex tablets and imprinted with black ink as follows: Table 2:
GLIPIZIDE extended-release tablet Presentations Tablet Strength Tablet Color/ Shape Tablet Markings Package Size NDC Code 2.5 mg blue round biconvex imprinted with βP β on one side. 2.5 Bottles of 30 NDC 64980-279-03 5 mg white round biconvex imprinted with βP β on one side. 5 Bottles of 100 NDC 64980-280-01 imprinted with βP β on one side. 5 Bottles of 500 NDC 64980-280-05 imprinted with βP β on one side. 5 Bottles of 1000 NDC 64980-280-10 10 mg white round biconvex imprinted with βP β on one side. 10 Bottles of 100 NDC 64980-281-01 imprinted with βP β on one side. 10 Bottles of 500 NDC 64980-281-05 imprinted with βP β on one side. 10 Bottles of 1000 NDC 64980-281-10 Recommended Storage: The tablets should be protected from moisture and humidity. Store at 20Β° to 25Β°C (68Β° to 77ΒΊ F); [see USP Controlled Room Temperature].
More pills like ROUND P 10